Catherine W. Ramsey

On Monday, Illumina, Inc. (NASDAQ: ILMN) announced preliminary Q4 results, while issuing the 2017 guidance and announcing the launch of its new sequencing platform, NovaSeq. Baird’s Catherine W. Ramsey maintains a Neutral rating on the company, while raising the price target from $147 to $153...

Cerus Corporation (NASDAQ: CERS) continues to see U.S. launch momentum, with a majority of Blood Centers of America (BCA) platelet volumes under contract and the first American Red Cross (ARC) site going live. Baird’s Catherine W. Ramsey reiterated an Outperform rating on the company,...